-
January 09, 2023 06:00 PM IST The vaccine, sold under brand name Covaxin, showed an immune response in individuals who had not received a COVID vaccine previously as well as those vaccinated with mRNA vaccines by Pfizer Inc and Moderna Inc, meeting its main goals, Ocugen said.
-
January 09, 2023 05:56 PM IST Covaxin was found to be well-tolerated in vaccine-naïve individuals and in individuals previously vaccinated with mRNA vaccines in the US with no vaccine-related serious adverse events, Bharat Biotech’s partner in the country has announced
- January 07, 2023 01:42 PM IST
Vaccination following exposure to the Delta or Omicron variants of SARS-CoV-2 is likely to affect the quality, quantity and duration of immune responses.
- November 17, 2022 01:38 PM IST
There have been media reports claiming that Bharat Biotech, manufacturer of the indigenous COVID-19 vaccine Covaxin, had to skip certain processes and 'speed' up clinical trials due to political pressure, the ministry said.
- November 06, 2022 11:14 AM IST
As the infection rate has been sturdily declining globally, exports of Covaxin were negatively impacted with poor off take by foreign countries.
- August 16, 2022 02:12 PM IST
With Bharat Biotech completing clinical trials of its vaccine candidate, hopes have been raised about the availability of intranasal vaccine as a booster dose just as the number of daily Covid-19 cases and test positivity rate in parts of India have started surging over the last few weeks.
- August 10, 2022 11:37 AM IST
This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country.
- July 20, 2022 05:54 PM IST
The findings of the study have been published in the high-impact scientific journal Nature.
- July 18, 2022 12:20 PM IST
On July 17, India administered its 2 billionth COVID-19 vaccine dose, 18 months after the mammoth vaccination drive against coronavirus was launched. Of the total doses administered, 51 percent doses were given to women and 71 percent vaccination centres were in rural areas
- July 08, 2022 06:22 PM IST
Our specially curated package of the most interesting articles to help you stay at the top of your game.
- July 08, 2022 05:46 PM IST
Biological E’s Corbevax has been recommended for administration in 5 to 12 years old children, while the Bharat Biotech’s Covaxin has been recommended for children in 6-12 years’ age group.
- June 20, 2022 06:10 PM IST
This is a remarkable feat, considering that all the vaccine doses administered in the country are made locally
- June 17, 2022 03:15 PM IST
In a phase II/III research, Bharat Biotech International Ltd's COVID-19 vaccine Covaxin was found to be safe, well-tolerated, and highly immunogenic in children and adolescents aged 2 to 18 years.
- June 17, 2022 11:14 AM IST
The company said that no adverse events of special interest have been reported to date. However, a supplementary surveillance study is going on, which will provide more information on rarer adverse events
- June 16, 2022 10:02 PM IST
Bharat Biotech, the manufacturer of Covaxin, announced on Thursday that his business can now forecast a pandemic based on changes in viral and related signals.
- June 15, 2022 12:20 PM IST
The protective efficacy of Bharat Biotech's Covaxin following two and three-dose immuniszations against the Delta variant and the efficacy of the Covaxin against Omicron variants were studied in a Syrian hamster model (animal model to study human-associated diseases), it said.
- June 07, 2022 11:03 PM IST
Bharat Biotech did not immediately react to the development, but company sources reportedly said that all export orders already stand cancelled as the production has been halted.
- June 06, 2022 01:30 PM IST
The pharma regulator has approved the first mix-and-match of COVID-19 vaccines in India, but the final say-so lies with the government
- May 26, 2022 02:07 PM IST
German Ambassador to India and Bhutan, Walter J Lindner on Thursday said the government of the European nation will start recognizing Bharat Biotech’s COVID-19 vaccine for travel purpose there from June 1.
- May 24, 2022 06:53 PM IST
The FDA’s earlier decision, in April, to put on hold the trials was based on the US firm’s decision to voluntarily implement a temporary pause in dosing participants of the jab, following the World Health Organisation’s observations on Covaxin manufacturing plants in India.
- May 05, 2022 09:36 PM IST
Covovax, the Covid-19 vaccine manufactured by the Serum Institute of India under licence from US firm Novavax, will be available at Rs 225 per dose, excluding taxes, at private healthcare facilities.
- May 04, 2022 04:46 PM IST
Presently, precaution dose of Covaxin and Covishield is administered to all those aged above 18 who have completed nine months after the second dose.
- April 28, 2022 07:51 PM IST
In a communication to Dr V K Paul, the convenor of a key empowered group on COVID vaccination, on Tuesday the Ministry of External Affairs said many issues about vaccines and international travel by Indians have arisen and these must be addressed immediately.
- April 28, 2022 05:29 PM IST
When asked if the gap for taking the booster dose has been reduced from nine months to six, the minister said, NTAGI is the panel to take decisions in this regard.
- April 27, 2022 11:46 AM IST
Government approval for the administration of COVID-19 vaccines to children in the 5-11-year age group is possible as early as next week, according to health ministry officials familiar with the situation.
